Cleared Traditional

K190833 - AXS Vecta Aspiration Catheter

K190833 is an FDA 510(k) clearance for AXS Vecta Aspiration Catheter, manufactured by Stryker Neurovascular. The device is a Class 2 Neurology device with product code DQY cleared through the Traditional 510(k) pathway after a 258-day FDA review.

K190833 · Stryker Neurovascular · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2019
Decision
258d
Days
Class 2
Risk

K190833 is an FDA 510(k) clearance for the AXS Vecta Aspiration Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Stryker Neurovascular (Fremont, US). The FDA issued a Cleared decision on December 15, 2019 after a review of 258 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Neurovascular devices

FDA 510(k) Submission Details - K190833

510(k) Number K190833 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2019
Decision Date December 15, 2019
Days to Decision 258 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 148d · This submission: 258d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 780
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K190833.
BioCardia 8F Morph DNA Deflectable Guide Catheter
K192774 · Biocardia · Jan 2020
VIA Microcatheter (size 17), VIA Microcatheter (size 21), VIA Microcatheter (size 27), VIA Microcatheter (size 33)
K192135 · MicroVention, Inc. · Dec 2019
RIST Cath Radial Access Long Sheath
K191551 · Rist Neurovascular, Inc. · Dec 2019
Lumax Guiding Catheter
K191163 · Cook Incorporated · Dec 2019
ASAHI CROSSWALK Peripheral Support Catheter
K192782 · Asahi Intecc Co., Ltd. · Nov 2019
AXS Infinity LS Plus Long Sheath
K193034 · Stryker Neurovascular · Nov 2019